Quick Answer
Pulmonx Corp reported Total Revenue of $90.50 million for the year ending 2025.
- Pulmonx Corp showed an increase of +8.0% in Total Revenue from 2024 to 2025.
- This data is from Pulmonx Corp's annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: $5.78 million | Q2 2019: $7.37 million | Q3 2019: $9.10 million | Q4 2019: $10.35 million | Q1 2020: $8.62 million | Q2 2020: $3.67 million | Q3 2020: $10.61 million | Q4 2020: $9.83 million | Q1 2021: $9.24 million | Q2 2021: $12.20 million | Q3 2021: $13.26 million | Q1 2022: $10.79 million | Q2 2022: $13.95 million | Q3 2022: $13.50 million | Q1 2023: $14.54 million | Q2 2023: $17.19 million | Q3 2023: $17.67 million | Q1 2024: $18.85 million | Q2 2024: $20.78 million | Q3 2024: $20.39 million | Q1 2025: $22.54 million | Q2 2025: $23.86 million | Q3 2025: $21.50 million.
- Over the full 8 years of available data (2018 to 2025), Pulmonx Corp's Total Revenue has grown by 352.4%.
- Historical annual values: Fiscal year 2025: $90.50 million | Fiscal year 2024: $83.79 million | Fiscal year 2023: $68.68 million | Fiscal year 2022: $53.66 million | Fiscal year 2021: $48.42 million | Fiscal year 2020: $32.73 million | Fiscal year 2019: $32.60 million | Fiscal year 2018: $20.00 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: